Cargando…

SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment

Detalles Bibliográficos
Autores principales: Bojkova, Denisa, Rothenburger, Tamara, Ciesek, Sandra, Wass, Mark N., Michaelis, Martin, Cinatl, Jindrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087166/
https://www.ncbi.nlm.nih.gov/pubmed/35538050
http://dx.doi.org/10.1038/s41421-022-00408-z
_version_ 1784704143651241984
author Bojkova, Denisa
Rothenburger, Tamara
Ciesek, Sandra
Wass, Mark N.
Michaelis, Martin
Cinatl, Jindrich
author_facet Bojkova, Denisa
Rothenburger, Tamara
Ciesek, Sandra
Wass, Mark N.
Michaelis, Martin
Cinatl, Jindrich
author_sort Bojkova, Denisa
collection PubMed
description
format Online
Article
Text
id pubmed-9087166
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-90871662022-05-10 SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment Bojkova, Denisa Rothenburger, Tamara Ciesek, Sandra Wass, Mark N. Michaelis, Martin Cinatl, Jindrich Cell Discov Correspondence Springer Nature Singapore 2022-05-10 /pmc/articles/PMC9087166/ /pubmed/35538050 http://dx.doi.org/10.1038/s41421-022-00408-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Bojkova, Denisa
Rothenburger, Tamara
Ciesek, Sandra
Wass, Mark N.
Michaelis, Martin
Cinatl, Jindrich
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
title SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
title_full SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
title_fullStr SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
title_full_unstemmed SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
title_short SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
title_sort sars-cov-2 omicron variant virus isolates are highly sensitive to interferon treatment
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087166/
https://www.ncbi.nlm.nih.gov/pubmed/35538050
http://dx.doi.org/10.1038/s41421-022-00408-z
work_keys_str_mv AT bojkovadenisa sarscov2omicronvariantvirusisolatesarehighlysensitivetointerferontreatment
AT rothenburgertamara sarscov2omicronvariantvirusisolatesarehighlysensitivetointerferontreatment
AT cieseksandra sarscov2omicronvariantvirusisolatesarehighlysensitivetointerferontreatment
AT wassmarkn sarscov2omicronvariantvirusisolatesarehighlysensitivetointerferontreatment
AT michaelismartin sarscov2omicronvariantvirusisolatesarehighlysensitivetointerferontreatment
AT cinatljindrich sarscov2omicronvariantvirusisolatesarehighlysensitivetointerferontreatment